Decreased expression of Sox7 correlates with the upregulation of the Wnt/β-catenin signaling pathway and the poor survival of gastric cancer patients

  • Authors:
    • Jianxin Cui
    • Hongqing Xi
    • Aizhen Cai
    • Shibo Bian
    • Bo Wei
    • Lin Chen
  • View Affiliations

  • Published online on: April 25, 2014     https://doi.org/10.3892/ijmm.2014.1759
  • Pages: 197-204
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Sox7 is a tumor suppressor gene that plays an important role in the inhibition and progression of cancer. In the present study, we sought to investigate Sox7 expression in gastric cancer (GC) and its association with the Wnt/β-catenin signaling pathway. We also wished to determine its clinicopathological significance and prognostic implications. Sox7 expression and its effects on the Wnt/β-catenin signaling in vitro were assessed by reverse transcription-polymerase chain reaction using the AGS, MKN-45 and GES-1 gastric cell lines. We also used immunohistochemistry on paraffin-embedded tissue samples and western blot analysis on fresh tissue samples from patients with GC. The results revealed that Sox7 expression was significantly lower in the GC samples than in distal normal tissues, which was in accordance with our results obtained from our in vitro experiments on the cell lines. However, the expression levels of β-catenin were significantly higher. Sox7 and β-catenin expression significantly correlated with the depth of invasion, lymph node metastasis, distant metastasis and the TNM stage. Patient samples that were Sox7-negative correlated with a significantly shorter survival time. Multivariate survival analysis revealed that Sox7 and β-catenin had an independent effect on the survival of GC patients. Sox7 and β-catenin expression in GC had a negative liner correlation with each other. Our findings suggest that Sox7 plays an important role in inhibiting tumorigenesis and progression, and may be a potential marker for predicting the prognosis of patients with GC.

References

1 

Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin. 61:69–90. 2011. View Article : Google Scholar

2 

Hartgrink HH, Jansen EP, van Grieken NC and van de Velde CJ: Gastric cancer. Lancet. 374:477–490. 2009. View Article : Google Scholar

3 

Bowles J, Schepers G and Koopman P: Phylogeny of the SOX family of developmental transcription factors based on sequence and structural indicators. Dev Biol. 227:239–255. 2000. View Article : Google Scholar : PubMed/NCBI

4 

Chew LJ and Gallo V: The Yin and Yang of Sox proteins: Activation and repression in development and disease. J Neurosci Res. 87:3277–3287. 2009. View Article : Google Scholar : PubMed/NCBI

5 

Shiozawa M, Hiraoka Y, Komatsu N, Ogawa M, Sakai Y and Aiso S: Cloning and characterization of Xenopus laevis xSox7 cDNA. Biochim Biophys Acta. 1309:73–76. 1996. View Article : Google Scholar

6 

Taniguchi K, Hiraoka Y, Ogawa M, Sakai Y, Kido S and Aiso S: Isolation and characterization of a mouse SRY-related cDNA, mSox7. Biochim Biophys Acta. 1445:225–231. 1999. View Article : Google Scholar : PubMed/NCBI

7 

Stovall DB, Wan M, Miller LD, et al: The regulation of SOX7 and its tumor suppressive role in breast cancer. Am J Pathol. 183:1645–1653. 2013. View Article : Google Scholar : PubMed/NCBI

8 

Guo L, Zhong D, Lau S, et al: Sox7 is an independent checkpoint for beta-catenin function in prostate and colon epithelial cells. Mol Cancer Res. 6:1421–1430. 2008. View Article : Google Scholar : PubMed/NCBI

9 

Endo Y, Deonauth K, Prahalad P, Hoxter B, Zhu Y and Byers SW: Role of Sox-9, ER81 and VE-cadherin in retinoic acid-mediated trans-differentiation of breast cancer cells. PLoS One. 3:e27142008. View Article : Google Scholar : PubMed/NCBI

10 

Gandillet A, Serrano AG, Pearson S, Lie ALM, Lacaud G and Kouskoff V: Sox7-sustained expression alters the balance between proliferation and differentiation of hematopoietic progenitors at the onset of blood specification. Blood. 114:4813–4822. 2009. View Article : Google Scholar : PubMed/NCBI

11 

Kamachi Y and Kondoh H: Sox proteins: regulators of cell fate specification and differentiation. Development. 140:4129–4144. 2013. View Article : Google Scholar : PubMed/NCBI

12 

Chan DW, Mak CS, Leung TH, Chan KK and Ngan HY: Down-regulation of Sox7 is associated with aberrant activation of Wnt/b-catenin signaling in endometrial cancer. Oncotarget. 3:1546–1556. 2012.PubMed/NCBI

13 

Katoh M: Expression of human SOX7 in normal tissues and tumors. Int J Mol Med. 9:363–368. 2002.PubMed/NCBI

14 

Hayano T, Garg M, Yin D, et al: SOX7 is down-regulated in lung cancer. J Exp Clin Cancer Res. 32:172013. View Article : Google Scholar : PubMed/NCBI

15 

Futaki S, Hayashi Y, Emoto T, Weber CN and Sekiguchi K: Sox7 plays crucial roles in parietal endoderm differentiation in F9 embryonal carcinoma cells through regulating Gata-4 and Gata-6 expression. Mol Cell Biol. 24:10492–10503. 2004. View Article : Google Scholar

16 

Zhang Y, Huang S, Dong W, et al: SOX7, down-regulated in colorectal cancer, induces apoptosis and inhibits proliferation of colorectal cancer cells. Cancer Lett. 277:29–37. 2009. View Article : Google Scholar : PubMed/NCBI

17 

Zhong WD, Qin GQ, Dai QS, et al: SOXs in human prostate cancer: implication as progression and prognosis factors. BMC Cancer. 12:2482012. View Article : Google Scholar : PubMed/NCBI

18 

Logan CY and Nusse R: The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol. 20:781–810. 2004. View Article : Google Scholar : PubMed/NCBI

19 

Karim R, Tse G, Putti T, Scolyer R and Lee S: The significance of the Wnt pathway in the pathology of human cancers. Pathology. 36:120–128. 2004. View Article : Google Scholar : PubMed/NCBI

20 

Polakis P: Wnt signaling in cancer. Cold Spring Harb Perspect Biol. 4:2012. View Article : Google Scholar

21 

Kolligs FT, Bommer G and Goke B: Wnt/beta-catenin/tcf signaling: a critical pathway in gastrointestinal tumorigenesis. Digestion. 66:131–144. 2002. View Article : Google Scholar : PubMed/NCBI

22 

Zhao P, Li Y and Lu Y: Aberrant expression of CD133 protein correlates with Ki-67 expression and is a prognostic marker in gastric adenocarcinoma. BMC Cancer. 10:2182010. View Article : Google Scholar : PubMed/NCBI

23 

Xi HQ and Zhao P: Clinicopathological significance and prognostic value of EphA3 and CD133 expression in colorectal carcinoma. J Clin Pathol. 64:498–503. 2011. View Article : Google Scholar : PubMed/NCBI

24 

Filomena A, Saieva C, Lucchetti V, et al: Gastric cancer surveillance in a high-risk population in tuscany (Central Italy): preliminary results. Digestion. 84:70–77. 2011. View Article : Google Scholar : PubMed/NCBI

25 

Wegner M: From head to toes: the multiple facets of Sox proteins. Nucleic Acids Res. 27:1409–1420. 1999. View Article : Google Scholar : PubMed/NCBI

26 

Kormish JD, Sinner D and Zorn AM: Interactions between SOX factors and Wnt/beta-catenin signaling in development and disease. Dev Dyn. 239:56–68. 2010.PubMed/NCBI

27 

Willert K and Nusse R: Beta-catenin: a key mediator of Wnt signaling. Curr Opin Genet Dev. 8:95–102. 1998. View Article : Google Scholar : PubMed/NCBI

28 

Wu WK, Cho CH, Lee CW, et al: Dysregulation of cellular signaling in gastric cancer. Cancer Lett. 295:144–153. 2010. View Article : Google Scholar : PubMed/NCBI

29 

Chan DW, Chan CY, Yam JW, Ching YP and Ng IO: Prickle-1 negatively regulates Wnt/beta-catenin pathway by promoting Dishevelled ubiquitination/degradation in liver cancer. Gastroenterology. 131:1218–1227. 2006. View Article : Google Scholar : PubMed/NCBI

30 

Qi J and Zhu YQ: Targeting the most upstream site of Wnt signaling pathway provides a strategic advantage for therapy in colorectal cancer. Curr Drug Targets. 9:548–557. 2008. View Article : Google Scholar : PubMed/NCBI

31 

Takash W, Canizares J, Bonneaud N, et al: SOX7 transcription factor: sequence, chromosomal localisation, expression, transactivation and interference with Wnt signalling. Nucleic Acids Res. 29:4274–4283. 2001. View Article : Google Scholar

32 

Li B, Ge Z, Song S, et al: Decreased expression of SOX7 is correlated with poor prognosis in lung adenocarcinoma patients. Pathol Oncol Res. 18:1039–1045. 2012. View Article : Google Scholar : PubMed/NCBI

33 

Castillo SD and Sanchez-Cespedes M: The SOX family of genes in cancer development: biological relevance and opportunities for therapy. Expert Opin Ther Targets. 16:903–919. 2012. View Article : Google Scholar : PubMed/NCBI

Related Articles

Journal Cover

July 2014
Volume 34 Issue 1

Print ISSN: 1107-3756
Online ISSN:1791-244X

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Cui, J., Xi, H., Cai, A., Bian, S., Wei, B., & Chen, L. (2014). Decreased expression of Sox7 correlates with the upregulation of the Wnt/β-catenin signaling pathway and the poor survival of gastric cancer patients. International Journal of Molecular Medicine, 34, 197-204. https://doi.org/10.3892/ijmm.2014.1759
MLA
Cui, J., Xi, H., Cai, A., Bian, S., Wei, B., Chen, L."Decreased expression of Sox7 correlates with the upregulation of the Wnt/β-catenin signaling pathway and the poor survival of gastric cancer patients". International Journal of Molecular Medicine 34.1 (2014): 197-204.
Chicago
Cui, J., Xi, H., Cai, A., Bian, S., Wei, B., Chen, L."Decreased expression of Sox7 correlates with the upregulation of the Wnt/β-catenin signaling pathway and the poor survival of gastric cancer patients". International Journal of Molecular Medicine 34, no. 1 (2014): 197-204. https://doi.org/10.3892/ijmm.2014.1759